_________________
January 17, 2023 | ValGenesis, Inc., the market leader in enterprise Validation Lifecycle Management Systems (VLMS), today announced that a leading pharmaceutical manufacturer selected ValGenesis VLMS to digitize multiple validation processes across the organization after a rigorous audit of possible solutions.
In this partnership, QualiTech will implement and manage next-generation digital validation tools developed by ValGenesis, enabling clients to further strengthen risk and compliance across the GMP lifecycle.
“Digitizing validation processes is crucial for compliance-focused life sciences companies to be able to meet stringent global regulatory requirements,” says Dr. Siva Samy, CEO & Chief Product Strategist at ValGenesis.
ValGenesis, Inc and Orbis LabSystems have partnered to deliver best-in-class digital validation solutions for life science companies across Europe, with a focus on Ireland.
ValGenesis VLMS enforces standardization and compliance with 100% digital, risk-based validation software that integrates easily with any business system. This leads to significant gains, better monitoring, and adequate utilization of systems.
ValGenesis, Inc and LifeBee have partnered to deliver best-in-class business consulting and innovative digital validation solutions in GxP regulated areas such as manufacturing, quality assurance, laboratories, logistics, serialization, regulatory affairs and pharmacovigilance for biopharmaceutical, medical devices, and nutraceutical companies across Italy and Switzerland.
The company is building out a new, GMP-compliant facility for a new fermented product being brought to market. The company will implement the VLMS for equipment qualification and use ValGenesis e-Logbook for continuous monitoring of the equipment at their new facility.
“Implementing a digital validation lifecycle management solution as soon as a company opens its doors is rare. But we increasingly find that new age life sciences startups are determined to leverage digital automation and other smart factory capabilities from the outset,” says Dr. Siva Samy, CEO at ValGenesis.
ValGenesis CEO and Chief Product Strategist Dr. Siva Samy kicked off this year’s conference with an overview of 2022 and the product roadmap for 2023 and beyond.
In this partnership, QbD Pharmaceutical Services will implement and manage next-generation digital risk management, process validation verification tools developed by ValGenesis, enabling clients to further strengthen quality by design and process validation and verification across the GMP lifecycle. Both companies are working to release the full potential of digital transformation for clients, providing them with the best course for success in the new digital validation landscape.